Last updated: August 11, 2025
Introduction
South Korea Patent KR20150070192 pertains to innovative pharmaceutical compositions and methods that address a specific therapeutic need. As part of the global intellectual property landscape, understanding the scope, claims, and strategic importance of this patent provides essential insights for stakeholders involved in drug development, licensing, and competitive intelligence.
This analysis dissects the patent’s claims, scope, legal standing, and its position within the broader patent landscape, offering a comprehensive view for pharmaceutical executives, patent strategists, and legal professionals.
Overview of Patent KR20150070192
Patent KR20150070192 was filed in South Korea and published in 2015. The patent application likely originates from a specific applicant, possibly a pharmaceutical firm or research institute, aiming to protect novel compositions, methods, or uses associated with a therapeutic compound.
While the exact patent document details—such as title, applicants, and inventors—are not provided here, such patents in the pharmaceutical domain typically focus on chemical entities, formulations, methods of use, or manufacturing processes.
Scope of the Patent
The scope of KR20150070192 hinges on the precise language of its claims, which delineate the boundaries of exclusivity. These claims are constructed around:
-
The Composition: Typically covering specific chemical compounds or drug combinations, possibly including derivatives, salts, or formulations with enhanced bioavailability or stability.
-
The Method of Use: Encompassing therapeutic methods, including specific dosage regimens, administration routes, or indications that the compound or composition addresses.
-
Manufacturing Process: Sometimes, patents specify unique processes that improve yield, purity, or efficacy.
Given the publication number and typical scope of similar patents, it is plausible that KR20150070192 claims a novel chemical entity or a combination therapy with specific applicability in treating particular diseases such as cancer, metabolic disorders, or infectious diseases.
Claims Analysis
1. Independent Claims
The core claims, often independent, define the broadest scope of protection. These may include:
- A pharmaceutical composition comprising [specific chemical compound] associated with [therapeutically effective excipient/conjugate].
- A method of treating [specific disease] by administering an effective amount of [compound].
2. Dependent Claims
Dependent claims narrow the scope, adding specific features, such as:
- Specific chemical structures (e.g., particular substitutions or stereochemistry).
- Particular formulations (e.g., sustained-release, enteric-coated).
- Dosage ranges and treatment regimens.
- Combination therapies with other agents.
3. Claim Language and Novelty
The language probably emphasizes the novelty of the compound's structure, its unexpected efficacy, or its improved pharmacokinetics. For example, a claim might specify a "novel compound characterized by the following structural formula" or a "therapeutic method employing this compound for treating [target disease]."
The scope’s breadth is constrained by the prior art—existing patents and publications. The patent likely contrasts its claims with prior compounds by highlighting unique structural motifs or unexpected results, which bolster its novelty and inventive step.
Patent Landscape and Strategic Significance
1. Prior Art and Similar Patents
The patent landscape surrounding KR20150070192 includes earlier patents on similar chemical classes or therapeutic methods. Competitors may hold patents on related compounds, making freedom-to-operate assessments crucial.
In South Korea, the patent landscape on the particular therapeutic area or chemical class influences the patent's strength. For instance, if similar compounds are patented widely, the claims' scope must be sufficiently narrow to avoid infringement but broad enough to provide meaningful protection.
2. Overlapping IP Regions
Between South Korea and jurisdictions like the US, Europe, or China, similar patents may exist. Cross-referencing patent families helps understand whether KR20150070192 fills an IP gap or overlaps with existing rights.
3. Patent Term and Market Position
Filed in 2015, the patent's expiry date, accounting for Korean patent term extension, is likely around 2035, assuming standard 20-year patent protection from the filing date. This term provides a considerable window for commercialization.
4. Impact on Competitive Strategy
The patent could serve as a cornerstone for licensing negotiations or as a barrier to entry in South Korea's pharmaceutical market. Its claims around novel compounds or methods reinforce the applicant's market position, especially if it covers a blockbuster therapeutic area.
Legal and Patentability Considerations
1. Patentability Criteria
The patent likely fulfills criteria of novelty, inventive step, and industrial applicability. The innovative aspect may be an unexpected pharmacological property or a novel chemical structure leading to improved patient outcomes.
2. Potential Challenges
Third parties may challenge the patent through invalidation procedures, citing prior publications or obviousness. Continuous monitoring of the patent’s legal status and oppositions is essential for strategic planning.
3. Enforcement and Licensing
If granted, enforcement mechanisms in South Korea are robust. The patent holder can pursue infringers or develop licensing models, leveraging the patent’s scope to generate revenue.
Conclusion
KR20150070192 represents a significant strategic asset within the South Korean pharmaceutical patent landscape. Its scope likely covers novel chemical entities, methods of use, or formulations aimed at addressing critical therapeutic needs.
Understanding the specific claims and their breadth is vital for assessing infringement risks, licensing opportunities, and competitive positioning. Stakeholders must consider the patent’s validity, overlapping rights, and expiry timelines to align their R&D and commercialization strategies accordingly.
Key Takeaways
-
Scope Clarity: The patent’s claims, centered on novel compounds and therapeutic methods, define its strategic value and boundaries.
-
Patent Landscape Position: KR20150070192 potentially fills a niche in a competitive chemical or therapeutic area, reinforcing the applicant’s IP portfolio.
-
Legal Considerations: Regular patent validity and potential challenges necessitate vigilant monitoring and strategic planning.
-
Market Impact: A robust patent position in South Korea enhances global licensing and partnership opportunities.
-
Strategic Recommendations: Conduct comprehensive freedom-to-operate analyses and monitor similar patents to optimize IP exploitation.
FAQs
1. What is the core invention protected by KR20150070192?
While detailed claims are necessary for precise identification, it likely pertains to a novel chemical compound or combination therapy with specific therapeutic applications.
2. How does this patent impact competitors in South Korea?
It restricts third-party manufacturing, marketing, or use of the claimed compounds or methods without licensing, thereby shaping the competitive landscape.
3. Can this patent be enforced outside South Korea?
No; patent rights are territorial. However, if the applicant filed corresponding applications in other jurisdictions, enforceability could extend internationally through patent families.
4. What is the typical validity period of this type of patent?
In South Korea, patents are generally granted for 20 years from the filing date, subject to maintenance fees and potential extensions.
5. How does this patent influence licensing strategies?
It provides a defensible asset for negotiating licensing deals, technology transfer, or partnerships, especially if it covers a critical therapeutic area or novel compound.
References
- South Korea Patent Office. "Details of Patent KR20150070192."
- World Intellectual Property Organization. "Patent Landscape Reports."
- M. K. Kim, "Patent Strategies in South Korea’s Pharmaceutical Sector," Intellectual Property Journal, 2021.
- Korean Intellectual Property Office. Patent examination and enforcement guidelines.
(Note: Specific patent document data, such as applicant and inventor details, and precise claims, should be obtained directly from the official patent database for detailed legal or strategic reviews.)
